title: [Reflux disease: standards, news and trends].
abstract: Proton pump inhibitors (PPI) are currently the standard treatment for reflux disease. A symptom correlated diagnosis with the help of 24-h-pH-metry and/or multiple intraluminal impedance (MII) allows the objective and differentiated classification of endoscopy-negative patients despite PPI symptoms.
authors: Medizinische Klinik und Poliklinik II, Klinikum der LMU München, Campus Grosshadern. Mathias.Nicolaus@med.unimuenchen.de
authors: M
authors: M
authors: Nicolaus
authors: J
authors: J
authors: Schirra
authors: B
authors: B
authors: Göke
mesh_terms: D000465:Algorithms; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017097:Electric Impedance; D050782:Esophageal pH Monitoring; D004942:Esophagitis, Peptic / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D004945:Esophagoscopy; D018662:Fundoplication; D006801:Humans; D054328:Proton Pump Inhibitors; D012008:Recurrence
chemical_list: D000863:Antacids; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors